Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioCore Strategies is a Massachusetts-based life sciences and healthcare consulting firm that provides strategic advisory services to biotechnology, diagnostics, medical technology, and broader life sciences clients. The firm appears to focus on portfolio strategy, commercialization, business development, partner management, intellectual property planning, and market access-oriented strategic support rather than developing its own therapeutic pipeline. BioCore Strategies is led by founder and principal Gregg Mayer, an industry executive with prior experience at Abbott Diagnostics, Chiron Diagnostics, EPIX Pharmaceuticals, Interleukin Genetics, and BG Medicine. Publicly available information indicates that the company works as an external advisor to emerging and mid-sized healthcare companies, including support for partnering and commercialization initiatives. It should be characterized as a specialized healthcare strategy consultancy rather than a drug developer, biotech platform company, or manufacturer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCore Strategies.